Atrial fibrillation

1,007,595views

Atrial fibrillation

Cardiothoracic Disease

Cardiothoracic Disease

Respiratory system anatomy and physiology
Lung volumes and capacities
Anatomic and physiologic dead space
Ventilation
Alveolar gas equation
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Alveolar surface tension and surfactant
Airflow, pressure, and resistance
Breathing cycle
Breathing control
Pulmonary chemoreceptors and mechanoreceptors
Ideal (general) gas law
Boyle's law
Dalton's law
Henry's law
Fick's laws of diffusion
Graham's law
Diffusion-limited and perfusion-limited gas exchange
Hypoxia
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Erythropoietin
Carbon dioxide transport in blood
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Pulmonary changes during exercise
Pulmonary changes at high altitude and altitude sickness
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Restrictive lung diseases
Idiopathic pulmonary fibrosis
Sarcoidosis
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Mesothelioma
Cardiovascular system anatomy and physiology
Lymphatic system anatomy and physiology
Cardiac cycle
Normal heart sounds
Abnormal heart sounds
Blood pressure, blood flow, and resistance
Resistance to blood flow
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Cardiovascular changes during hemorrhage
Cardiovascular changes during postural change
Measuring cardiac output (Fick principle)
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac conduction velocity
Excitability and refractory periods
Cardiac excitation-contraction coupling
Cardiac contractility
Cerebral circulation
Coronary circulation
Control of blood flow circulation
Microcirculation and Starling forces
Cardiomyopathies: Clinical
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Restrictive cardiomyopathy
Sleep apnea
Apnea of prematurity
Aortic aneurysms and dissections: Clinical
Aortic dissections and aneurysms: Pathology review
Aortic dissection
Aneurysms
Marfan syndrome
Peripheral vascular disease: Clinical
Peripheral artery disease: Pathology review
Peripheral artery disease
Arterial disease
Deep vein thrombosis
Leg ulcers: Clinical
Chronic venous insufficiency
Thrombophlebitis
Vasculitis: Pathology review
Vasculitis
Kawasaki disease
Behcet's disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Subclavian steal syndrome
Coronary steal syndrome
Lymphedema
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG intervals
ECG axis
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Heart blocks: Pathology review
Premature ventricular contraction
Premature atrial contraction
Atrial fibrillation
Atrial flutter
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Atrioventricular block
Bundle branch block
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Brugada syndrome
Ventricular fibrillation
Pulseless electrical activity
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Positive inotropic medications
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
cGMP mediated smooth muscle vasodilators
Calcium channel blockers
Heart failure: Clinical
Heart failure: Pathology review
Heart failure
Cor pulmonale
Pulmonary hypertension
Pulmonary edema
Anatomy of the coronary circulation
Asthma: Clinical
Obstructive lung diseases: Pathology review
Asthma
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic bronchitis
Emphysema
Alpha 1-antitrypsin deficiency
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Non-corticosteroid immunosuppressants and immunotherapies
Cystic fibrosis: Pathology review
Cystic fibrosis
Bronchiectasis
Anatomy of the heart
Anatomy clinical correlates: Heart
Cardiac muscle histology
Marfan syndrome
Ehlers-Danlos syndrome
Arteriole, venule and capillary histology
Cardiac muscle histology
Artery and vein histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Nasal cavity and larynx histology
Coarctation of the aorta
Mitral valve disease
Pulmonary valve disease
Tricuspid valve disease
Aortic valve disease
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Coronary artery disease: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Coronary steal syndrome

Transcript

Watch video only

Atrial fibrillation, sometimes called Afib for short, is the most common cardiac arrhythmia, which occurs when the atria contract way faster than expected and in a disorganized manner. As a result, the atria have a quivering or twitching movement that can’t pump blood into the ventricles efficiently.

Now, let’s cover some physiology of the cardiac conduction system. The cardiac conduction system is made up of specialized myocardial cells that can create and transport electrical potential, also called an action potential. These cells have many special features, including automaticity, meaning that they can generate an impulse; excitability, which is the ability to respond to a stimulus by creating an electrical impulse; conductivity meaning they can carry the impulse to other cells; and contractility, which is the ability to shorten the length of their fibers, causing a contraction.

Alright, now let’s look at the normal electrical conduction pathway in the heart on an ECG, which shows how the depolarization wave flows through the heart during each heartbeat. The normal electrical activity of the heart starts in the sinoatrial or SA node, which is considered the pacemaker of the heart.

Then, the impulse is conducted through the atria , causing depolarization and creating the P wave on an ECG. When the atrial muscle cells get depolarized, they contract, pushing blood from the atria into the ventricles.

From the atria, the impulse goes to the atrioventricular, or AV node, where the impulse propagation speed slows way down. The interval from the atrial depolarization to just before ventricular depolarization is the PR interval on an ECG. This delay allows the atria to

contract while the ventricles fill with blood.

From the AV node, the impulse goes through the Bundle of His, then to the right and left bundle branches, and finally through the Purkinje fibers, which deliver the impulse to the right and left

ventricles, causing them to depolarize, and is represented by the QRS complex on an ECG. This triggers simultaneous contraction of both ventricles, pushing blood into the systemic and pulmonary circulations. Finally, the ventricles repolarize to prepare for the next cycle, which allows them to relax and fill with blood, called diastole. And on ECG, ventricular repolarization will create a T wave, while the phase between ventricular depolarization and repolarization is represented by the ST segment. Sometimes, immediately after the T wave, there’s a U wave, which represents late repolarization of the ventricles.

Okay, now, atrial fibrillation is typically caused by any kind of structural damage to the heart or any damage to the heart's electrical conduction system. Often, these changes are strongly associated with several cardiovascular disorders and risk factors. For example, high blood pressure, coronary artery disease, valvular diseases, essentially anything that can create an inflammatory state or physically stretches the atria, may potentially damage the cells in the atria and lead to atrial fibrillation.

Other risk factors include older age, and a family history of heart disease or atrial fibrillation; as well as sleep apnea, obesity, diabetes, thyrotoxicosis, which means excess levels of thyroid hormones; and excessive alcohol consumption.

These factors likely stress and damage the cells in the atria, which can lead to tissue heterogeneity; in other words, cells start taking on different electrical properties, generating impulses from many foci in a totally disorganized manner,

which tends to override the sinoatrial node. So instead of one efficient atrial contraction, clients get all these mini contractions, usually between 350 and 600 per minute, that make it look like the atria are just quivering.

Sometimes, signals from one of these areas make it down to the ventricles and cause irregular ventricular contraction; these QRS complexes are interspersed at irregular intervals, though, and usually at high rates, between 100 and 150 beats per minute. As a result, the ventricular filling is also impaired, which reduces cardiac output.

Additionally, the inefficient emptying of the atria into the ventricles can cause blood to stay in the atria for longer than usual, allowing it to form atrial clots. This is especially concerning in the left atrium, which has a small pocket where the blood can collect, and clots are most likely to form. So, with atrial fibrillation, there’s a chance that one of these clots can get pumped from the atria into the ventricles, and from there, into the systemic circulation.

From there, the clot can get lodged in a cerebral artery, causing a stroke, or in other systemic arteries, blocking blood flow to areas such as the kidney, spleen, or extremities.

Often, people with atrial fibrillation start by experiencing paroxysmal events, which means AFib suddenly comes and goes, lasting less than a week at a time, probably because the tissue is still relatively healthy. Repeated paroxysmal events over extended periods stress the atrial cells even more. Over time, the cells in the atrium undergo progressive fibrosis or scarring, which means the AFib episodes didn’t terminate spontaneously in less than a week.

AFib episodes that last longer than one week are called persistent AFib; when it lasts for more than 12 months, it’s called long-standing persistent AFib. Finally, when long-standing persistent AFib is left untreated or doesn’t respond to treatment, that’s called permanent atrial fibrillation; in time, it can lead to heart failure.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Atrial Fibrillation" Annals of Internal Medicine (2017)
  5. "Atrial fibrillation" Journal of Biomedical Research (2014)
  6. "Risk Factors and Genetics of Atrial Fibrillation" Cardiology Clinics (2014)
  7. "Atrial Fibrillation" Circulation Research (2017)
  8. "Critical care nursing: Diagnosis and management (10th ed.) ISBN: 978-0-443-11581-3 " Elsevier (2026)
  9. "Lewis’s Medical-Surgical Nursing: Assessment and Management of Clinical Problems. 12th Edition. ISBN:978-0-323-78961-5 " Elsevier
  10. "Guyton and Hall Textbook of Medical Physiology. ISBN 978-0323597128 " Elsevier (2020)
  11. "Mosby’s® Diagnostic and Laboratory Test Reference. 15th edition. ISBN: 978-0-323-67519-2 " Mosby (2020 )
  12. "Fundamentals of Nursing. 11th edition. ISBN: 978-0-323-81034-0 " Elsevier (2022)
  13. "Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. 23(1):6." Int J Mol Sci (2021 Dec 21)
  14. "Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. 127(1):4-20. " Circ Res. (2020)
  15. "Mortality in atrial fibrillation. Is it changing?. 31(8):469-473." Trends Cardiovasc Med. (2021)